ru 26988 has been researched along with 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione in 1 studies
Studies (ru 26988) | Trials (ru 26988) | Recent Studies (post-2010) (ru 26988) | Studies (16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione) | Trials (16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione) | Recent Studies (post-2010) (16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione) |
---|---|---|---|---|---|
47 | 0 | 0 | 116 | 0 | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fullerton, MJ; Funder, JW; Gannell, JE; Quirk, SJ | 1 |
1 other study(ies) available for ru 26988 and 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione
Article | Year |
---|---|
Progestins specifically suppress alpha-lactalbumin synthesis and secretion.
Topics: Androstanols; Animals; Binding, Competitive; Female; Insulin; Lactalbumin; Mammary Glands, Animal; Pregnancy; Pregnenediones; Progesterone Congeners; Progestins; Prolactin; Rats; Receptors, Progesterone | 1985 |